- Home
- LSCC vs CORT Comparison
LSCC vs CORT Comparison
Compare LSCC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSCC
- CORT
- Stock Information
- Founded
- LSCC 1983
- CORT 1998
- Country
- LSCC United States
- CORT United States
- Employees
- LSCC N/A
- CORT N/A
- Industry
- LSCC Semiconductors
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- LSCC Technology
- CORT Health Care
- Exchange
- LSCC Nasdaq
- CORT Nasdaq
- Market Cap
- LSCC 6.9B
- CORT 7.5B
- IPO Year
- LSCC 1989
- CORT N/A
- Fundamental
- Price
- LSCC $53.23
- CORT $72.93
- Analyst Decision
- LSCC Strong Buy
- CORT Strong Buy
- Analyst Count
- LSCC 12
- CORT 4
- Target Price
- LSCC $63.58
- CORT $142.00
- AVG Volume (30 Days)
- LSCC 2.3M
- CORT 1.6M
- Earning Date
- LSCC 07-28-2025
- CORT 07-28-2025
- Dividend Yield
- LSCC N/A
- CORT N/A
- EPS Growth
- LSCC N/A
- CORT 8.36
- EPS
- LSCC 0.37
- CORT 1.14
- Revenue
- LSCC $488,736,000.00
- CORT $685,446,000.00
- Revenue This Year
- LSCC $3.41
- CORT $35.83
- Revenue Next Year
- LSCC $18.44
- CORT $35.24
- P/E Ratio
- LSCC $145.21
- CORT $62.92
- Revenue Growth
- LSCC N/A
- CORT 30.93
- 52 Week Low
- LSCC $34.69
- CORT $30.77
- 52 Week High
- LSCC $70.55
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- LSCC 56.15
- CORT 50.50
- Support Level
- LSCC $50.58
- CORT $66.49
- Resistance Level
- LSCC $56.75
- CORT $72.49
- Average True Range (ATR)
- LSCC 1.88
- CORT 2.85
- MACD
- LSCC 0.29
- CORT -0.09
- Stochastic Oscillator
- LSCC 55.09
- CORT 49.95
About LSCC Lattice Semiconductor Corporation
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.